 |
|
Eruptive Xanthomas Associated With Intravenous Miconazole Therapy
Ronald J. Barr, MD;
Wayne H. Fujita, MD;
James H. Graham, MD
Arch Dermatol. 1978;114(10):1544-1545.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
Multiple eruptive xanthomas developed in a 69-year-old man with disseminated coccidioidomycosis who was being treated with intravenous (IV) miconazole. These lesions rapidly cleared when therapy was stopped. Although the carrier solution in parenteral miconazole has been associated with serum lipoprotein abnormalities, including a prominent hypertriglyceridemia, cutaneous manifestations have not been previously described.
Report of a Case
In February 1977, a 69-year-old man with a two-year history of chronic disseminated coccidioidomycosis was admitted. Physical examination at the time showed no skin lesions. Important laboratory findings included several mildly elevated fasting blood sugars, which ranged from 100 to 150 mg/dl (normal, 58 to 100 mg/dl) and were compatible with a past medical history of adult-onset diabetes that was well controlled with diet alone. Cultures from bone marrow and sputum were positive for Coccidioides immitis. Amphotericin B therapy was instituted, but was stopped because of renal and bone-marrow toxicity. In August 1977, IV
. . . [Full Text PDF of this Article]
Author Affiliations
From the Division of Dermatology, Section of Dermal Pathology and Histochemistry, University of California College of Medicine at Irvine, and the Dermatology Section, Veterans Administration Hospital, Long Beach, Calif.
Footnotes
Accepted for publication June 23, 1978.
Reprint requests to the Section of Dermal Pathology and Histochemistry, University of California Irvine Medical Center, 101 City Drive South, Orange, CA 92668 (Dr Barr).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
